• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血液透析患者的铁代谢——故事只讲了一半?

Iron metabolism in hemodialyzed patients - a story half told?

作者信息

Malyszko Jolanta, Koc-Zorawska Ewa, Levin-Iaina Nomy, Slotki Itzchak, Matuszkiewicz-Rowinska Joanna, Glowinska Irena, Malyszko Jacek S

机构信息

2 Department of Nephrology, Medical University, Bialystok, Poland.

1 Department of Nephrology, Medical University, Bialystok, Poland.

出版信息

Arch Med Sci. 2014 Dec 22;10(6):1117-22. doi: 10.5114/aoms.2014.47823.

DOI:10.5114/aoms.2014.47823
PMID:25624847
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4296069/
Abstract

INTRODUCTION

All living organisms have evolved sophisticated mechanisms to maintain appropriate iron levels in their cells and within their body. Recently our understanding of iron metabolism has dramatically increased. Overt labile plasma iron (LPI) represents a component of non-transferrin bound iron (NTBI) that is both redox active and chelatable, capable of permeating into organs and inducing tissue iron overload. The LPI measures the iron-specific capacity of a given sample to produce reactive oxygen species. We studied for the first time NTBI correlations with markers of iron status and inflammation in prevalent hemodialyzed patients.

MATERIAL AND METHODS

Complete blood count, urea, serum lipids, fasting glucose, creatinine, ferritin, serum iron, total iron binding capacity (TIBC) were studied by standard laboratory method. The NTBI was assessed commercially available kits from Aferrix Ltd in Tel Aviv, Israel. A test result of 0.6 units of LPI or more indicates a potential for iron-mediated production of reactive oxygen species in the sample.

RESULTS

Patients with LPI units ≥ 0.6 had higher serum iron, erythropoiesis stimulating agents (ESA) dose, ferritin, high-sensitivity C-reactive protein (hsCRP), hepcidin and lower hemojuvelin. In hemodialyzed patients NTBI correlated with hsCRP (r = 0.37, p < 0.01), ferritin (r = 0.41, p < 0.001), IL-6 (r = 0.43, p < 0.001). In multivariate analysis predictors of NTBI were hemoglobin and alkaline phosphatase, explaining 58% of the variability.

CONCLUSIONS

Elevated NTBI in HD may be due to disturbed iron metabolism. Anemia and liver function might also contribute to the presence of NTBI in this population.

摘要

引言

所有生物都进化出了复杂的机制来维持细胞和体内适当的铁水平。最近,我们对铁代谢的理解有了显著提高。明显的不稳定血浆铁(LPI)是非转铁蛋白结合铁(NTBI)的一个组成部分,它具有氧化还原活性且可螯合,能够渗透到器官中并导致组织铁过载。LPI测量给定样本产生活性氧的铁特异性能力。我们首次研究了NTBI与普遍存在的血液透析患者铁状态和炎症标志物之间的相关性。

材料与方法

通过标准实验室方法研究全血细胞计数、尿素、血脂、空腹血糖、肌酐、铁蛋白、血清铁、总铁结合力(TIBC)。NTBI使用以色列特拉维夫Aferrix Ltd公司的市售试剂盒进行评估。LPI为0.6单位或更高的测试结果表明样本中存在铁介导的活性氧产生的可能性。

结果

LPI单位≥0.6的患者血清铁、促红细胞生成素(ESA)剂量、铁蛋白、高敏C反应蛋白(hsCRP)、铁调素较高,而血色素沉着蛋白较低。在血液透析患者中,NTBI与hsCRP(r = 0.37,p < 0.01)、铁蛋白(r = 0.41,p < 0.001)、白细胞介素-6(r = 0.43,p < 0.001)相关。在多变量分析中,NTBI的预测指标是血红蛋白和碱性磷酸酶,可解释58%的变异性。

结论

血液透析患者中NTBI升高可能是由于铁代谢紊乱。贫血和肝功能也可能导致该人群中NTBI的存在。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31d2/4296069/959ba34b606e/AMS-10-24188-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31d2/4296069/959ba34b606e/AMS-10-24188-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31d2/4296069/959ba34b606e/AMS-10-24188-g001.jpg

相似文献

1
Iron metabolism in hemodialyzed patients - a story half told?血液透析患者的铁代谢——故事只讲了一半?
Arch Med Sci. 2014 Dec 22;10(6):1117-22. doi: 10.5114/aoms.2014.47823.
2
Iron metabolism in kidney allograft recipients: still a mystery?肾移植受者的铁代谢:仍是一个谜团?
Transplant Proc. 2011 Oct;43(8):2973-5. doi: 10.1016/j.transproceed.2011.08.055.
3
Lack of non-transferrin-bound iron in heart transplant recipients.心脏移植受者中非转铁蛋白结合铁的缺乏
Transplant Proc. 2011 Oct;43(8):3068-70. doi: 10.1016/j.transproceed.2011.08.033.
4
Hemojuvelin and iron metabolism in kidney and heart allograft recipients.肾和心脏移植受者中的血色素沉着症相关蛋白与铁代谢
Transplant Proc. 2013 Jan-Feb;45(1):391-3. doi: 10.1016/j.transproceed.2012.02.041.
5
Iron overload across the spectrum of non-transfusion-dependent thalassaemias: role of erythropoiesis, splenectomy and transfusions.非输血依赖型地中海贫血症中的铁过载:红细胞生成、脾切除术及输血的作用
Br J Haematol. 2017 Jan;176(2):288-299. doi: 10.1111/bjh.14373. Epub 2016 Dec 5.
6
Is hemojuvelin a possible new player in iron metabolism in hemodialysis patients?在血液透析患者的铁代谢中,血红素结合蛋白是否是一个可能的新角色?
Int Urol Nephrol. 2012 Dec;44(6):1805-11. doi: 10.1007/s11255-011-0084-x. Epub 2011 Dec 1.
7
Unbalance in Iron Metabolism in Childhood Leukemia Converges with Treatment Intensity: Biochemical and Clinical Analysis.儿童白血病铁代谢失衡与治疗强度相关:生化与临床分析
Cancers (Basel). 2021 Jun 17;13(12):3029. doi: 10.3390/cancers13123029.
8
Non-transferrin bound iron in Thalassemia: differential detection of redox active forms in children and older patients.地中海贫血中的非转铁蛋白结合铁:儿童和老年患者中氧化还原活性形式的差异检测。
Am J Hematol. 2012 Jan;87(1):55-61. doi: 10.1002/ajh.22203. Epub 2011 Nov 28.
9
Is hepcidin a link between anemia, inflammation and liver function in hemodialyzed patients?铁调素是血液透析患者贫血、炎症与肝功能之间的联系吗?
Am J Nephrol. 2005 Nov-Dec;25(6):586-90. doi: 10.1159/000089266. Epub 2005 Oct 25.
10
Labile plasma iron in iron overload: redox activity and susceptibility to chelation.铁过载中不稳定血浆铁:氧化还原活性及螯合敏感性
Blood. 2003 Oct 1;102(7):2670-7. doi: 10.1182/blood-2003-03-0807. Epub 2003 Jun 12.

引用本文的文献

1
The Relationship Between Non-Transferrin-Bound Iron (NTBI), Labile Plasma Iron (LPI), and Iron Toxicity.非转铁蛋白结合铁(NTBI)、不稳定血浆铁(LPI)与铁毒性之间的关系
Int J Mol Sci. 2025 Jul 3;26(13):6433. doi: 10.3390/ijms26136433.
2
Role of redox iron towards an increase in mortality among patients: a systemic review and meta-analysis.氧化还原铁在患者死亡率增加方面的作用:一项系统评价和荟萃分析。
Blood Res. 2019 Jun;54(2):87-101. doi: 10.5045/br.2019.54.2.87. Epub 2019 Jun 25.
3
Augmented mitochondrial cytochrome c oxidase activity in children with iron deficiency: a tandem between iron and copper?

本文引用的文献

1
Cardiorenal Syndrome and the Role of the Bone-Mineral Axis and Anemia.心肾综合征以及骨矿物质轴和贫血的作用。
Am J Kidney Dis. 2015 Aug;66(2):196-205. doi: 10.1053/j.ajkd.2014.12.016. Epub 2015 Feb 26.
2
Treatment of non-ST-elevation myocardial infarction and ST-elevation myocardial infarction in patients with chronic kidney disease.慢性肾脏病患者的非 ST 段抬高型心肌梗死和 ST 段抬高型心肌梗死的治疗。
Arch Med Sci. 2013 Dec 30;9(6):1019-27. doi: 10.5114/aoms.2013.39792. Epub 2013 Dec 26.
3
Serum p-cresyl sulfate predicts cardiovascular disease and mortality in elderly hemodialysis patients.
缺铁儿童线粒体细胞色素c氧化酶活性增强:铁与铜之间的关联?
Arch Med Sci. 2018 Jan;14(1):151-156. doi: 10.5114/aoms.2016.59602. Epub 2016 Apr 27.
4
Fibroblast growth factor 23, iron and inflammation - are they related in early stages of chronic kidney disease?成纤维细胞生长因子23、铁与炎症——它们在慢性肾脏病早期有关联吗?
Arch Med Sci. 2017 Jun;13(4):845-850. doi: 10.5114/aoms.2016.58647. Epub 2016 Mar 17.
5
Vascular adhesion protein-1 in hemodialysis and hemodiafiltration patients: effect of single hemodialysis session on its level in regard to type of anticoagulant.血液透析和血液透析滤过患者体内的血管黏附蛋白-1:单次血液透析治疗对其水平的影响与抗凝剂类型的关系
Int Urol Nephrol. 2017 May;49(5):875-879. doi: 10.1007/s11255-016-1497-3. Epub 2017 Jan 2.
6
In vivo behavior of NTBI revealed by automated quantification system.通过自动定量系统揭示的非转铁蛋白结合铁(NTBI)的体内行为。
Int J Hematol. 2016 Aug;104(2):175-81. doi: 10.1007/s12185-016-2002-6. Epub 2016 Apr 16.
7
Effects of dialyzer reuse on dialysis adequacy, anemia control, erythropoieting-stimulating agents use and phosphate level.透析器复用对透析充分性、贫血控制、促红细胞生成素使用及血磷水平的影响。
Arch Med Sci. 2016 Feb 1;12(1):219-21. doi: 10.5114/aoms.2016.57599. Epub 2016 Feb 2.
8
Correlation of iron deposition and change of gliocyte metabolism in the basal ganglia region evaluated using magnetic resonance imaging techniques: an in vivo study.利用磁共振成像技术评估基底节区铁沉积与神经胶质细胞代谢变化的相关性:一项体内研究。
Arch Med Sci. 2016 Feb 1;12(1):163-71. doi: 10.5114/aoms.2016.57593. Epub 2016 Feb 2.
血清对甲酚硫酸盐可预测老年血液透析患者的心血管疾病和死亡率。
Arch Med Sci. 2013 Aug 30;9(4):662-8. doi: 10.5114/aoms.2013.36901. Epub 2013 Aug 8.
4
Biochemistry of adipose tissue: an endocrine organ.脂肪组织的生物化学:一个内分泌器官。
Arch Med Sci. 2013 Apr 20;9(2):191-200. doi: 10.5114/aoms.2013.33181. Epub 2013 Feb 10.
5
Iron metabolism in solid‑organ transplantation: how far are we from solving the mystery?实体器官移植中的铁代谢:我们距离解开谜团还有多远?
Pol Arch Med Wewn. 2012;122(10):504-11.
6
IMproving the imPlemEntation of cuRrent guidelines for the mAnagement of major coronary hearT disease rIsk factors by multifactorial interVEntion. The IMPERATIVE renal analysis.改善多重因素干预对主要冠状动脉心脏疾病风险因素管理现行指南执行情况。强制性肾脏分析。
Arch Med Sci. 2011 Dec 31;7(6):984-92. doi: 10.5114/aoms.2011.26610. Epub 2011 Dec 30.
7
Editorial on management of diabetes mellitus with coronary artery disease.关于合并冠状动脉疾病的糖尿病管理的社论
Arch Med Sci. 2011 Dec 31;7(6):928-30. doi: 10.5114/aoms.2011.26601. Epub 2011 Dec 30.
8
Non-transferrin bound iron in Thalassemia: differential detection of redox active forms in children and older patients.地中海贫血中的非转铁蛋白结合铁:儿童和老年患者中氧化还原活性形式的差异检测。
Am J Hematol. 2012 Jan;87(1):55-61. doi: 10.1002/ajh.22203. Epub 2011 Nov 28.
9
Lack of non-transferrin-bound iron in heart transplant recipients.心脏移植受者中非转铁蛋白结合铁的缺乏
Transplant Proc. 2011 Oct;43(8):3068-70. doi: 10.1016/j.transproceed.2011.08.033.
10
Iron metabolism in kidney allograft recipients: still a mystery?肾移植受者的铁代谢:仍是一个谜团?
Transplant Proc. 2011 Oct;43(8):2973-5. doi: 10.1016/j.transproceed.2011.08.055.